Pulmonx Corp (LUNG) - Form 8-K Summary
Business Context and Reporting Period
Pulmonx Corporation, a Delaware corporation, filed this Current Report on Form 8-K on July 29, 2026. The filing announces the financial results for the second fiscal quarter ended June 30, 2026. The company's common stock trades on The Nasdaq Stock Market LLC under the symbol "LUNG."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial data and analysis of operational changes.
Guidance, Outlook, and Risks
This Form 8-K serves as a notification of the results announcement and does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies within the provided text. Such information is expected to be found in the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 29, 2026) for actual Q2 2026 revenue and net income figures.
- Verify year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any updated full-year 2026 financial guidance provided in the press release.
- Confirm cash position and liquidity metrics as reported in the full earnings release.